Caldwell Sutter Capital, Inc. Glaukos Corp Transaction History
Caldwell Sutter Capital, Inc.
- $234 Billion
- Q3 2025
A detailed history of Caldwell Sutter Capital, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 20 shares of GKOS stock, worth $1,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 45
55.56%
Holding current value
$1,800
Previous $4.65 Million
64.91%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GKOS
# of Institutions
350Shares Held
55.3MCall Options Held
163KPut Options Held
458K-
Black Rock Inc. New York, NY8.04MShares$724 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$544 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.58MShares$322 Million0.05% of portfolio
-
Primecap Management CO Pasadena, CA2.25MShares$203 Million0.15% of portfolio
-
State Street Corp Boston, MA2.1MShares$189 Million0.01% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.29B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...